mirikizumab
eli lilly
['mirikizumab', 'ulcerative colitis']
b0377: effect of mirikizumab (anti-p19) on abdominal pain scores in the phase lucent trials in ulcerative colitis #acg2022 
I'm a Mayo specialist in evaluation and management of patients with ulcerative colitis and Crohn's disease. Tweets are mine. Retweet doesn't mean endorsement.